Clinical Trial
- Business Wire
VFMCRP announces positive results of phase-III clinical trial of Velphoro® in China
Met primary efficacy endpoint of non-inferiority versus sevelamer carbonate Velphoro® effective in lowering and maintaining serum phosphorus level Safety profile…
Read More » - World
Brii Biosciences, Vir Biotechnology, and VBI Vaccines Announce Initiation of Phase 2 Clinical Trial of BRII-835 (VIR-2218) in Combination with BRII-179 (VBI-2601) for the Treatment of Hepatitis B
DURHAM, N.C. & BEIJING & SAN FRANCISCO & CAMBRIDGE, Mass.: Brii Biosciences (Brii Bio), Vir Biotechnology, Inc. (Nasdaq: VIR), and…
Read More » - World
LintonPharm Announces Authorization from China Health Authority (NMPA) to Proceed with a Phase 1/2 Trial Evaluating Catumaxomab for the treatment of Non-Muscle Invasive Bladder Cancer
Guangzhou, China: LintonPharm Co., Ltd., a China-based clinical stage biopharmaceutical company focused on the development of T cell engaging bispecific…
Read More » - United States
Tanner Pharma Group Expands Ex-US Access Program to Provide LEUKINE® for Use in Patients with Respiratory Illness Associated with COVID-19
Charlotte, N.C., United States: Topline clinical trial results showed LEUKINE® was safe, well tolerated and generated T cells targeted at…
Read More » - Technology
YEAR END REVIEW-2020: CSIR, M/o Science & Technology
Major Highlights: 10-Bedded Makeshift Hospital inaugurated at NDRF 8th Battalion Centre, Ghaziabad A modern, durable, portable, fast installable, safe and…
Read More » - Health
Research Protocol on Ayurvedic Treatment of COVID-19 by Team of Doctors From Pune, Published in Reputed International Journal
Pune, Maharashtra, India: A paper on an ayurvedic protocol designed by a team of doctors from Pune led by Dr. Suresh…
Read More » - Business
GenesisCare Clinical CRO Adopts Veeva Vault Clinical Applications to Accelerate and Scale Studies Globally
Sydney, Australia: Veeva Systems (NYSE: VEEV) today announced that contract research organisation (CRO) GenesisCare Clinical CRO, founded by GenesisCare, has adopted Veeva…
Read More » - Business
Positive Results From ProDERM Study of octagam® 10% in Patients With Dermatomyositis Meeting the Primary Endpoint Will Be Presented at ACR Convergence 2020
LACHEN, Switzerland: Octapharma announces that the final results from the phase III ProDERM study will be presented at the American…
Read More » - Business
Takeda FY2020 H1 Results Demonstrate Portfolio Resilience; Confirms Full-Year Management Guidance & Raises Forecasts for Free Cash Flow, Reported OP & Reported EPS
Osaka, Japan: FY2020 H1 results driven by growth of global brands (e.g. Entyvio +25.8% YOY, TAKHZYRO +45.5% YOY, NINLARO +…
Read More » - Health
Boehringer Ingelheim Begins Phase 2 Clinical Trial of a Targeted Therapy to Help People with Severe Respiratory Illness from COVID-19
Ingelheim, Germany: Trial will evaluate BI 764198, a novel first-in-class compound, for hospitalized people infected with SARS-CoV-2 with severe respiratory…
Read More » - Health
Boehringer Ingelheim and Oxford BioTherapeutics Expand Collaboration to Discover Novel Selective Tumor Targets as First Bispecific Antibody Advanced into the Clinic
Oxford, England & Ingelheim, Germany: The collaboration for the discovery of novel selective tumor targets for Boehringer Ingelheim’s unique T-cell…
Read More » - World
Takeda Accelerates Digital Transformation with Accenture and AWS
Osaka, Japan & Seattle, New York, United States: Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE: TAK) (“Takeda”), Accenture (NYSE: ACN) and…
Read More » - Health
Safety and Efficacy of Subcutaneous Entyvio® (Vedolizumab) Sustained During Long-term Maintenance Therapy in Adults with Moderately to Severely Active Ulcerative Colitis
Osaka, Japan: Interim analysis from VISIBLE OLE study showed long-term findings consistent with the known safety profile of vedolizumab with…
Read More »